Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Pulmonary Arterial Hypertension
NCT00477269Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2006
- Primary completion
- Jan 2014
- Countries
- 4
01
Overview
A Phase 3 trial of imatinib in pulmonary arterial hypertension (PAH), sponsored by Novartis. Started Apr 2006; status: completed.
02
Drugs
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00477269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477269.